Evidence map›Paper›PMID 42698951›Full record

ArticleJournal of the colleges of medicine of South Africa2026

Investigating visual field measurements on perimetry and ganglion cell complex on optical coherence tomography in patients with suprasellar tumours.

Saajidah Gaibie, Susan Williams

Abstract read
In one paragraph

Article in Journal of the colleges of medicine of South Africa, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Saajidah GaibieDepartment of Neurosciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.ORCID https://orcid.org/0009-0005-1002-3489
Susan WilliamsDepartment of Neurosciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.ORCID https://orcid.org/0000-0002-4479-8638

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Suprasellar tumours can cause compressive optic neuropathy with preventable visual loss. Standard automated perimetry is central to assessment but is subjective; optical coherence tomography (OCT) provides ganglion cell complex (GCC) metrics, yet structure-function relationships in chiasmal compression remain unclear. This study evaluated the relationship between GCC thickness and visual field (VF) loss (10-2 and 30-2). Methods: Prospective observational study of patients with suprasellar tumours undergoing OCT GCC imaging and Humphrey VF testing (10-2 and 30-2). Ganglion cell complex abnormality was defined as a machine-flagged red value. Visual field abnormality was defined on the pattern deviation (PD) map as a scotoma (≥ 3 adjacent points with Results: Seventeen eyes were included (mean age 50.7 years; 70.0% female). Visual field abnormality was frequent (10-2: 82.4%; 30-2: 94.1%), while GCC was abnormal in 58.8%. Mean PD was -6.84 dB (10-2) and -8.66 dB (30-2). Ganglion cell complex thickness correlated with PD at 10-2 ( Conclusion: Visual field abnormalities were common, with 30-2 classifying more eyes as abnormal despite normal GCC. Ganglion cell complex thickness showed a graded association with VF loss on both strategies, supporting OCT GCC as an adjunct for quantifying chiasmal compression-related dysfunction; however, binary OCT classification may miss milder functional deficits. Contribution: Supports combined OCT-perimetry interpretation and strategy-aware follow-up.

Indexed as

chiasmal compressionganglion cell complexoptical coherence tomographyperimetrystructure–function relationshipsuprasellar tumoursvisual fields

Identifiers

PMID42698951
PMCPMC13543280

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.